Theranos
Theranos, worked to develop blood-testing technology that would perform a wide range of tests using just a few drops of blood taken from a finger prick, making blood testing quicker, easier, and less invasive than traditional methods.
Founded in 2003, Theranos set out to transform the diagnostics industry by enabling fast, affordable, and minimally invasive blood testing using just a few drops of blood from a finger prick. Led by founder Elizabeth Holmes, the company promised to deliver rapid results for a wide range of tests through compact, automated devices. Theranos gained massive attention, securing partnerships with major retailers and appearing on magazine covers as a Silicon Valley breakthrough. However, the technology failed to perform as claimed, and investigations revealed systemic issues with its science and operations. Despite its collapse, Theranos left a lasting impact on the diagnostics field and inspired a wave of innovation in medical testing.
Testimonial
Related Companies
Klona Biotech
The future of human tissue replacements using 3D printing
London, United Kingdom
Lyric Bio
Pioneering the future of biomanufacturing using proven and proprietary 3D bioprinting and tissue engineering technologies
San Carlos, California
Eywa Biotech
Scaling the production of pharmaceutical-grade psychedelic compounds through synthetic biology
Montevideo, Uruguay · Buenos Aires, Argentina
PrettyLitter
Develops a lightweight cat litter that helps cat owners monitor their pets' health by changing colors in response to abnormalities in urine.
Los Angeles, United States
nVision
nVision’s focus is on women’s health. The company created the first FDA-cleared device for collecting cells from the fallopian tubes, which aimed to enable earlier diagnosis of ovarian cancer. In 2018, nVision was acquired by Boston Scientific.
Senodia
MEMS sensors for various applications.
China, Shanghai
Aanika
Innovative science-backed insurance solutions for agriculture and food industries with Bio technology.
Brooklyn, United States
